6.72
+0.19
+(2.91%)
At close: January 30 at 4:00:01 PM EST
6.13
-0.59
(-8.78%)
Pre-Market: 4:35:03 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AKKARAJU SRINIVAS Director | Stock Award(Grant) | Jul 1, 2024 | -- |
| AYURMAYA CAPITAL MANAGEMENT COMPANY, LP Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jul 1, 2024 | -- |
| BABLER MARTIN Chief Executive Officer | Stock Award(Grant) | Jul 1, 2024 | -- |
| FORESITE CAPITAL MANAGEMENT V, LLC. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 1, 2024 | -- |
| FORESITE LABS, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 1, 2024 | -- |
| GOLDSTEIN DAVID M PH.D. Officer | Stock Award(Grant) | Jul 1, 2024 | -- |
| HARDIMAN ROY CHARLES Officer | Stock Award(Grant) | Jul 1, 2024 | -- |
| KLEIN SARA MARION General Counsel | Stock Award(Grant) | Jul 1, 2024 | 33,796 |
| TANANBAUM JAMES B Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 1, 2024 | -- |
| YAO ZHENGBIN Director | Stock Award(Grant) | Jul 1, 2024 | 23,529 |
Related Tickers
LXEO Lexeo Therapeutics, Inc.
5.25
+0.77%
MBX MBX Biosciences, Inc.
11.64
+13.34%
AVBP ArriVent BioPharma, Inc.
29.09
+0.24%
ARTV Artiva Biotherapeutics, Inc.
5.40
+0.37%
BCAX Bicara Therapeutics Inc.
12.91
+9.78%
ZBIO Zenas BioPharma, Inc.
7.62
+4.53%
SEPN Septerna, Inc.
17.71
+13.89%
UPB Upstream Bio, Inc.
11.00
+7.32%
CGON CG Oncology, Inc.
30.15
-0.46%
PLRX Pliant Therapeutics, Inc.
10.66
-0.74%